Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Burning Mouth Syndrome
NCT03788733Unknown
- Sponsor
- Universidad de Murcia
- Start
- Dec 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in burning mouth syndrome (BMS), sponsored by Universidad de Murcia. Primary endpoint: Pittsburgh Sleep Quality Index at 8 weeks. Status: unknown.
02
Drugs
melatonin
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT03788733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788733.